HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $151,000 | -79.6% | 14,081 | -69.2% | 0.00% | -100.0% |
| Q1 2021 | $742,000 | +267.3% | 45,788 | +378.8% | 0.00% | – |
| Q4 2020 | $202,000 | +17.4% | 9,564 | -18.1% | 0.00% | – |
| Q2 2020 | $172,000 | +35.4% | 11,684 | +8.3% | 0.00% | – |
| Q1 2020 | $127,000 | -52.4% | 10,791 | -5.2% | 0.00% | – |
| Q4 2019 | $267,000 | -2.9% | 11,382 | -23.3% | 0.00% | – |
| Q3 2019 | $275,000 | -52.7% | 14,842 | -52.6% | 0.00% | -100.0% |
| Q2 2019 | $582,000 | -4.1% | 31,303 | +25.9% | 0.00% | 0.0% |
| Q1 2019 | $607,000 | -0.8% | 24,855 | +5.3% | 0.00% | 0.0% |
| Q4 2018 | $612,000 | -26.0% | 23,605 | -9.7% | 0.00% | 0.0% |
| Q3 2018 | $827,000 | -26.9% | 26,127 | -10.2% | 0.00% | -50.0% |
| Q2 2018 | $1,131,000 | +41.6% | 29,109 | +0.6% | 0.00% | +100.0% |
| Q1 2018 | $799,000 | – | 28,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |